Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders.
about
Review article: new receptor targets for medical therapy in irritable bowel syndromeAtypical antipsychotics as a possible treatment option for irritable bowel syndrome.Psychopharmacological treatment and psychological interventions in irritable bowel syndrome.Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms.Abuse, trauma, and GI illness: is there a link?Review article: the functional abdominal pain syndrome.Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.When is irritable bowel syndrome not irritable bowel syndrome? Diagnosis and treatment of chronic functional abdominal pain.New treatments for IBS.The use of psychotropic drugs in irritable bowel syndrome.The narcotic bowel syndrome: a recent update.Centrally targeted pharmacotherapy for chronic abdominal pain.Outcomes of Ultrasound-Guided Trigger Point Injection for Abdominal Wall Pain.Central Neuromodulators for Treating Functional GI Disorders: A Primer.Opioid misuse in gastroenterology and non-opioid management of abdominal pain.Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome.Centrally Targeted Pharmacotherapy for Chronic Abdominal Pain: Understanding and Management.Ameliorative effect of chlorpromazine hydrochloride on visceral hypersensitivity in rats: possible involvement of 5-HT2A receptor.'Idiopathic' intestinal failure--the importance of identifying and treating primary psychopathology.
P2860
Q33959307-AA012EF5-227A-46C8-92C9-ABCA40183266Q34333642-357B718B-13B6-463A-839B-35FC5E0B71C6Q36203967-9B291C80-6095-40B7-9C87-350FB51671CCQ37643415-7CDC91DB-0083-4546-859A-2ACBDD69F3DCQ37817712-049FE6E0-B4E2-4EBD-8FBB-7765B2F5F18EQ37825923-9ABDDEAD-CA75-41A4-A1FB-2568DAE773D6Q37954521-904EAC29-7590-4DE1-BACB-89A925C8ACA5Q38014362-917547C1-26EA-4755-A626-0627A8FBDE72Q38059436-099637FA-C94D-4C06-ABB4-9720DF774B08Q38073816-836779C1-1ED1-4DBE-882C-593391FCC4FEQ38248064-F1BEBB96-4BE2-4FBB-99C2-EADDFCB30427Q38343940-3564058A-7D5B-44F4-B095-A9A26B3B2792Q39184123-C418B971-115E-432A-B091-D58F64E1B61CQ39204575-D47B1590-3C47-4AE5-861D-A63036DDCDB9Q44350905-D48DC8FB-7DD3-4B2A-AB3B-FCBAA75F75AEQ46033333-120C903C-598F-45DB-937C-32CC09AC17E7Q48306528-8BCF2707-D00A-4DD1-B698-7284096B418DQ48335208-A8590500-F3A7-43DB-B249-8E2F2D7B046AQ50775882-B008FECD-5FE4-4C19-A0E5-15A457EBE699
P2860
Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Atypical antipsychotic quetiap ...... al gastrointestinal disorders.
@en
Atypical antipsychotic quetiap ...... al gastrointestinal disorders.
@nl
type
label
Atypical antipsychotic quetiap ...... al gastrointestinal disorders.
@en
Atypical antipsychotic quetiap ...... al gastrointestinal disorders.
@nl
prefLabel
Atypical antipsychotic quetiap ...... al gastrointestinal disorders.
@en
Atypical antipsychotic quetiap ...... al gastrointestinal disorders.
@nl
P2093
P1476
Atypical antipsychotic quetiap ...... al gastrointestinal disorders.
@en
P2093
Christine B Dalton
Douglas A Drossman
Madhusudan Grover
Spencer D Dorn
Stephan R Weinland
P2860
P2888
P304
P356
10.1007/S10620-009-0723-6
P577
2009-02-26T00:00:00Z